NCT00023192View on ClinicalTrials.gov

Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

June 30, 2004

Conditions
Chronic Granulomatous Disease
Interventions
DRUG

T-Cell Depleted & CD34+Select/w/StemCell Enriched Product

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00023192 - Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care | Biotech Hunter | Biotech Hunter